Catalyst Wire Dossier Catalyst Wire Dossier

Aggrastat

tirofiban
Drug timelines are a Plus or Pro feature.

29 regulatory and trial events tracked for Aggrastat, covering 2007-10-31 to 2025-12-11. Get the full timeline:

Most recent: Clinical Trial Update: Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair [Phase 2, Phase 3]

See pricing